Methicillin-resistant staphylococcus aureus in wound cultures recovered from a combat support hospital in Iraq

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue SUPPL. 1, 2010, Pages

  Murray, Clinton K ^a,b   Griffith, Matthew E ^a,b   Mende, Katrin ^a,b,c   Guymon, Charles H ^d   Ellis, Michael W ^b   Beckius, Miriam ^e   Zera, Wendy C ^c   Yu, Xin ^e   Co, Edgie Mark A ^f   Aldous, Wade ^f   Hospenthal, Duane R ^a,b  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^e BROOKE ARMY MEDICAL CENTER   (United States)

^f 10th Combat Support Hospital   (Iraq)

Author keywords

Antibiotics; Community acquired; Hospital acquired; Iraq; MRSA; USA300; Wound

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; LEVOFLOXACIN; MOXIFLOXACIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CHROMOSOME; DRUG SENSITIVITY; GENOTYPE; HEALTH CARE FACILITY; HUMAN; IRAQ; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; MORPHOLOGICAL TRAIT; NONHUMAN; PATIENT CARE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; VIRULENCE; BACTERIUM ISOLATE; DRUG EXPOSURE; NOTE; OUTPATIENT; SKIN INFECTION; COMPARATIVE STUDY; GENETICS; HOSPITAL DISCHARGE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PREDICTIVE VALUE; PROGNOSIS; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; WAR; WOUND INFECTION;

DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS, MILITARY; HUMANS; INCIDENCE; IRAQ WAR, 2003 -; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT DISCHARGE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; WOUND INFECTION; IRAQ WAR, 2003-2011;

EID: 77954796908     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e44b57     Document Type: Article

References (52)

1. Fleming A. On the bacteriology of septic wounds. Lancet. 1915;2:638-643.
2. Ashcroft PG, Pulvertaft RJV. The bacteriology of head wounds. Br J Surg. 1947;1(suppl 1):183-186.
3. Ecker AD. A bacteriologic study of penetrating wounds of the brain from the surgical point of view. J Neurosurg. 1946;3:1-6.
4. Miles AA. Epidemiology of wound infection. Lancet. 1944;1:809-815.
5. Strawitz JG, Wetzler TF, Marshall JD, Lindberg RB, Howard JM, Artz CP. The bacterial flora of healing wounds. A study of the Korean Battle Casualty. Surgery. 1955;37:400-408.
6. Lyons C. Penicillin and its use in the war wounded. Am J Surg. 1946;72:315-318.
7. Witschi TH, Omer GE. The treatment of open tibial shaft fractures from Vietnam War. J Trauma. 1970;10:105-111.
8. Heggers JP, Barnes ST, Robson MC, Ristroph JD, Omer GE Jr. Microbial flora of orthopaedic war wounds. Mil Med. 1969;134:602-603.
9. Tong MJ. Septic complications of war wounds. JAMA. 1972;219:1044-1047.
10. Matsumoto T, Wyte SR, Moseley RV, Hawley RJ, Lackey GR. Combat surgery in communication zone. I. War wound and bacteriology (preliminary report). Mil Med. 1969;134:655-665.
11. Heisterkamp C III, Vernick J, Simmons RL, Motsumoto T. Topical antibiotics in war wounds: a re-evaluation. Mil Med. 1969;134:13-18.
12. Jacob E, Murphy KP, Erpelding JM. A retrospective analysis of open fractures sustained by U.S. military personnel during Operation Just Cause. Mil Med. 1992;157:552-556.
13. Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007;45:409-415.
14. Murray CK, Wilkins K, Molter NC, et al. Infections in combat casualties during Operations Iraqi and Enduring Freedom. J Trauma. 2009;66(4 Suppl):S138-S144.
15. Yun HC, Branstetter JG, Murray CK. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma. 2008;64:S163-S168.
16. Yun HC, Murray CK, Roop SA, Hospenthal DR, Gourdine E, Dooley DP. Bacteria recovered from patients admitted to a deployed U.S. military hospital in Baghdad, Iraq. Mil Med. 2006;171:821-825.
17. Murray CK, Roop SA, Hospenthal DR, et al. Bacteriology of war wounds at the time of injury. Mil Med. 2006;171:826-829.
18. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis. 2001;7:178-182.
19. Jevons MP. ["Celbenin"-resistant Staphylococci]. BMJ. 1961;1:124-125.
20. Crisostoma MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Nat Acad Science U S A. 2001;98:9865-9870.
21. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Nat Acad Science U S A. 2002;99:7687-7692.
22. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-598.
23. Blanc DS, Petignat C, Wenger A, et al. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J Clin Microbiol. 2007; 45:3729-3736.
24. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971-979.
25. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46: 787-794.
26. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-5120.
27. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Gen Evolut. 2008;8:747-763.
28. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006;367:731-739.
29. Said-Salim B, Mathema B, Braughton K, et al. Differential distribution and expression of Panton-Valentine leukocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol. 2005; 43:3373-3379.
30. Diep BA, Stone GG, Basuino L, et al. The arginine catabolic mobile element and Staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillinresistant Staphylococcus aureus. J Infect Dis. 2008;197:1523-1530.
31. Armed Forces Health Surveillance Center. Hospitalizations among members of active components. U.S. Armed Forces, 2008. Med Surv Month Rep. 2009;16:2-8.
32. Army Medical Surveillance Activity. Cellulitis and abscess, active components, U.S. Armed Forces, 2002-2005. Med Surv Month Rep. 2006;12:2-8.
33. Armed Forces Health Surveillance Center. "Indicator" infectious illnesses, staphylococcal infections, and penicillin resistance among active component members, U.S. Armed Forces, January 2002-June 2007. Med Surv Month Rep. 2007;14:2-7.
34. Army Medical Surveillance Activity. Cellulitis among active duty service members, U.S. Armed Forces, 1998-2001. Med Surv Month Rep. 2002;8:6-9.
35. Allen AM. Chapter III: Statistics. In: Ognibene AJ, ed. Internal Medicine in Vietnam. WA, DC: Office of the Surgeon General and Center for Military History, US Army; 1977:29-51.
36. Army Medical Surveillance Activity. Disease and non-battle injury surveillance among deployed US Armed Forces: Bosnia-Herzegovina, Kosovo, and Southwest Asia, July 2000-September 2001. Med Surv Month Rep. 2001;7:2-6.
37. Roberts SS, Karzagis RJ. Methicillin-resistant Staphylococcus aureus infections in U.S. Service members deployed to Iraq. Mil Med. 2009; 174:408-411.
38. Murray CK, Holmes RL, Ellis MW, et al. Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center. Burns. 2009;35:1112-1117.
39. Lewis JS, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologist be concerned? Clin Infect Dis. 2005;40:280-285.
40. Ellis MW, Griffith ME, Jorgensen JH, Hospenthal DR, Mende K, Patterson JE. Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. J Clin Microbiol. 2009;47:940-945.
41. Giordano PA, Elston D, Akinlade BK, et al. Cefdinir vs cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults. Curr Med Res Opin. 2006;22:2419-2428.
42. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillinresistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;51:4044-4048.
43. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007;44:777-784.
44. Kaplan El, Johnson DR, Del Rosario MD, Horn DL. Susceptibility of group A beta-hemolytic Streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Ped Infect Dis J. 1999;18:1069-1072.
45. Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers HF. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis. 2009;48:1483-1484.
46. Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:3298-3303.
47. Murray CK, Hsu JR, Solomkin JS, et al. Prevention and management of infections associated with combat-related extremity injuries. J Trauma. 2008;64:S239-S251.
48. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin- resistant Staphylococcus aureus strains in soldiers: a cluster randomization controlled trial. Antimicrob Agents Chemother. 2007;51:3591-3598.
49. Uniformed Services University of the Health Sciences. Chlorhexidine impregnated cloths to prevent skin and soft tissue infections in Marine officer candidates (US National Institutes of Health Web site). Available at: http://clinicaltrials.gov/ct2/show/NCT00475930. Accessed May 5, 2009.
50. Projan SJ, Nesin M, Dunman PM. Staphylococcal vaccines and immunotherpay: to dream the impossible dream. Curr Opinion Pharmacol. 2006;6:473-479.
51. Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines. 2008;7:805-815.
52. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infection in battlefield casualties from Iraq. Ann Surg. 2007;245:803-811.